Researchers have released new tools for analyzing epigenomic data as part of the International Human Epigenome Consortium.
At the Guardian, Jenny Rohn describes one ongoing approach to promote equality in the sciences.
The new firm, created by Syncona and Cancer Research Technology, has raised $17.5 million to support development of individualized therapies targeted to tumor neoantigens.
Living DNA can break down the origins of a customer’s ancestry into 21 distinct regions within Britain alone, as well as across 80 different worldwide populations.
A suite of papers from the Blueprint project suggests that epigenetic profiling may be ready for clinical use.
A genome-wide association study involving nearly 6,000 individuals identified variants linked to nose-related features and chin protrusion in Latin Americans.
The UK-based startup has developed a prototype intended to attract both experienced molecular and genetics researchers and enthusiastic amateurs.
Through a genome-wide association study, University College London researchers have linked certain SNPs to hair shape, graying, and unibrow, among other traits.
The goal is to detect both clonal and subclonal variations and to demonstrate how Natera's technology can help improve cancer patient care and treatment outcomes.
Faster sequencing of Mycobacterium tuberculosis from sputum samples and analysis of resistance genes could enable better disease treatment, the researchers said.
Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.
Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.
The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.
In Science this week: genetically modified flu virus could be key to new live vaccines, and more.